Cancers · 2019 · 62 citations · 27 references
MedicineOncologyPharmacologyBreast OncologyMetastasisMolecular OncologyBreast Cancer OncologyCancer BiomarkersCancer Survival AnalysisMetastatic Breast CancerMolecular Tumor ProfilingBreast Cancer PrognosisClinical Risk Prediction ToolsCox RegressionPrognostic BiomarkersPrognostic Factors AnalysisPrognostic PredictionPrognostic VariablesTreatment Survival Response
Background: Elevated plasmatic lactate dehydrogenase (LDH) levels are associated with worse prognosis in various malignancies, including metastatic breast cancer (MBC). Nevertheless, no data are available on the prognostic role of LDH as a dynamic biomarker during first-line treatment in unselected MBC. Methods: We reviewed data of 392 women with MBC to evaluate the association between LDH variation after 12 weeks of first-line treatment and survival. The prognostic impact was tested by multivariate Cox regression analysis. Results: Plasmatic LDH was confirmed as an independent prognostic factor in MBC. Patients who maintained elevated LDH levels after 12 weeks of first-line treatment experienced worse progression-free survival (PFS, HR 2.88, 95% CI: 1.40–5.89, p = 0.0038) and overall survival (OS, HR 2.61, 95% CI 1.16–5.86, p = 0.02) compared to patients with stable normal LDH levels, even after adjustment for other prognostic factors. Notably, LDH low-to-high variation emerged as an unfavorable prognostic factor for PFS (HR 3.96, 95% CI 2.00–7.82, p = 0.0001). Conclusions: Plasmatic LDH and its variation during first-line treatment predict PFS and OS in MBC, providing independent prognostic information. It would be worthwhile to prospectively evaluate the association between LDH variation and therapeutic benefit in MBC, and explore how it may affect treatment strategies.
27
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch, Jeffrey E. Gershenwald, Seng-Jaw Soong et al. · Journal of Clinical Oncology · 2009 · 4.6K citations · Full text
Cancer Cell Metabolism: Warburg and Beyond
Peggy P. Hsu, David M. Sabatini · Cell · 2008 · 2.5K citations · Full text
Breast cancer statistics, 2017, racial disparity in mortality by state
Carol DeSantis, Jiemin Ma, Ann Goding Sauer et al. · CA A Cancer Journal for Clinicians · 2017 · 1.9K citations · Full text